US Patent Issued to Rheinische-Friedrich-Wilhelms-Universitat Bonn, Katholieke Universiteit Leuven KU Leuven Research & Development on Oct. 6 for "MRGX receptor antagonists" (Belgian, German Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,953, issued on Oct. 6, was assigned to Rheinische-Friedrich-Wilhelms-Universitat Bonn (Bonn, Germany) and Katholieke Universiteit Leuven KU Leuven Research & Development (Leuven, Belgium).

"MRGX receptor antagonists" was invented by Christa Muller (Bonn, Germany), Mohamad Wessam Alnouri (Niederau, Germany), Yvonne Riedel (Bonn, Germany), Dominik Thimm (Bonn, Germany), Daniel Marx (Linz am Rhein, Germany), Vigneshwaran Namasivayam (Bonn, Germany), Susanne Gattner (Bonn, Germany), Piet Herdewyn (Heverlee, Belgium), Steven De Jonghe (Tervuren, Belgium), Piotr Leonczak (Leuven, Belgium) and Sven Verdonck (Diest, Belgium).

According to the abstract* released by the U.S. Patent & Tradem...